Navamedic ASA has entered into a market making agreement with Norne Securities AS

Publisert: 11.11.2021

Navamedic ASA: Q3 2021 financial results

Publisert: 04.11.2021

Navamedic ASA: Invitation to 2021 Third quarter presentation

Publisert: 28.10.2021

Navamedic ASA extends exclusive distribution rights for Mysimba in the Nordics

Publisert: 12.10.2021

Navamedic ASA receives approval for conditional reimbursement for Mysimba® in Finland

Publisert: 07.09.2021

Navamedic ASA: Q2 and first half 2021 financial results

Publisert: 13.08.2021